FULL TEST BANK FOR NEONATAL & PEDIATRIC
RESPIRATORY CARE 5th EDITION BY WALSH/ COMPLETE
CHAPTERS 1-36 PASS QUARANTEED.
, Table of Contents
Chapter 1: Fetal Lung Development ...........................................................................................................................................3
Chapter 2: Fetal Gas Exchange and Circulation Test Bank .........................................................................................................6
Chapter 3: Antenatal Assessment and High Risk Delivery Test Bank........................................................................................9
Chapter 4: Exam and Assessment of the Neonatal and Pediatric Patient Test Bank .................................................................18
Chapter 5: Pulmonary Function Testing and Bedside Pulmonary Mechanics Test Bank ..........................................................31
Chapter 6: Radiographic Assessment Test Bank ......................................................................................................................38
Chapter 7: Bronchoscopy Test Bank ........................................................................................................................................45
Chapter 8: Invasive Blood Gas Analysis and Monitoring Test Bank ......................................................................................53
Chapter 9: Noninvasive Monitoring in Neonatal and Pediatric Care Test Bank .......................................................................63
Chapter 10: Oxygen Administration Test Bank .......................................................................................................................70
Chapter 11: Aerosols and Administration of Medication Test Bank ........................................................................................75
Chapter 12: Airway Clearance Techniques and Lung Volume Expansion Test Bank ...............................................................83
Chapter 13: Airway Management Test Bank ...........................................................................................................................92
Chapter 14: Surfactant Replacement Therapy .......................................................................................................................101
Chapter 15: Non-invasive Mechanical Ventilation and Continuous Positive Pressure of the Neonate...............................103
Chapter 16: Noninvasive Mechanical Ventilation of the Infant and Child Answers to Assessment Questions ......................110
Chapter 16 Noninvasive Mechanical Ventilation of the Infant and Child ..............................................................................111
Chapter 17- Invasive Mechanical Ventilation of the Neonate and Pediatric Patient..............................................................121
Chapter 18: Administration of Gas Mixtures Test Bank........................................................................................................129
Chapter 19, Extracorporeal Membrane Oxygenation.............................................................................................................137
Chapter 20- Pharmacology .....................................................................................................................................................141
Chapter 21: Thoracic Organ Transplantation Test Bank ...............................................................................................................147
Chapter 22: Neonatal Pulmonary Disorders ..........................................................................................................................154
Chapter 22: Neonatal Pulmonary Disorders Answers to Case Studies ...................................................................................157
Chapter 23 Surgical Disorders in Childhood that Affect Respiratory Care ............................................................................159
Chapter 24: Congenital Cardiac Defects Test Bank ................................................................................................................164
Chapter 25 Pediatric Sleep-Disordered Breathing ..................................................................................................................174
Chapter 26: Pediatric Airway Disorders and Parenchymal Lung Diseases .............................................................................184
Chapter 27: Asthma Test Bank .................................................................................................................................................193
Chapter 28: Cystic Fibrosis Test Bank ....................................................................................................................................200
Chapter 29: Acute Respiratory Distress Syndrome Test Bank ................................................................................................206
Chapter 30: Shock...................................................................................................................................................................213
Chapter 31: Pediatric Trauma Test Bank .................................................................................................................................219
Chapter 32: Disorders of the Pleura ........................................................................................................................................238
Chapter 33: Neurological and Neuromuscular Disorders ......................................................................................................242
Chapter 34 Pediatric Emergencies ..........................................................................................................................................248
Chapter 35: Home Care of the Postpartum Family .................................................................................................................263
Chapter 36: Quality and Safety ...............................................................................................................................................269
, Chapter 1: Fetal Lung Development
Walsh: Neonatal & Pediatric Respiratory Care 5th Edition Test Bank (2020)
QNS WITH MUTIPLE CHOICES
1. Which of the following phases of human lung development is characterized by the formation
of a capillary network around airway passages?
a. Pseudoglandular
b. Saccular
c. Alveolar
d. Canalicular
CORRECT ANS: D
The canalicular phase follows the pseudoglandular phase, lasting from approximately 17
weeks to 26 weeks of gestation. This phase is so named because of the appearance of vascular
channels, or capillaries, which begin to grow by forming a capillary network around the air
passages. During the pseudoglandular stage, which begins at day 52 and extends to week 16
of gestation, the airway system subdivides extensively and the conducting airway system
develops, ending with the terminal bronchioles. The saccular stage of development, which
takes place from weeks 29 to 36 of gestation, is characterized by the development of sacs that
later become alveoli. During the saccular phase, a tremendous increase in the potential gas-
exchanging surface area occurs. The distinction between the saccular stage and the alveolar
stage is arbitrary. The alveolar stage stretches from 39 weeks of gestation to term. This stage
is represented by the establishment of alveoli.
REF: pp. 3-5
2. Regarding postnatal lung growth, by approximately what age do most of the alveoli that will
be present in the lungs for life develop?
a. 6 months
b. 1 year
c. 1.5 years
d. 2 years
CORRECT ANS: C
Most of the postnatal formation of alveoli in the infant occurs over the first 1.5 years of life.
At 2 years of age, the number of alveoli varies substantially among individuals. After 2 years
of age, males have more alveoli than do females. After alveolar multiplication ends, the
alveoli continue to increase in size until thoracic growth is completed.
REF: p. 6
3. The respiratory therapist is evaluating a newborn with mild respiratory distress due to tracheal
stenosis. During which period of lung development did this problem develop?
, a. Embryonal
b. Saccular
c. Canalicular
d. Alveolar
CORRECT ANS: A
The initial structures of the pulmonary tree develop during the embryonal stage. Errors in
development during this time may result in laryngeal, tracheal, or esophageal atresia or
stenosis. Pulmonary hypoplasia, an incomplete development of the lungs characterized by an
abnormally low number and/or size of bronchopulmonary segments and/or alveoli, can
develop during the pseudoglandular phase. If the fetus is born during the canalicular phase
(i.e., prematurely), severe respiratory distress can be expected because the inadequately
developed airways, along with insufficient and immature surfactant production by alveolar
type II cells, gives rise to the constellation of problems known as infant respiratory distress
syndrome.
REF: p. 6
4. Which of the following mechanisms is (are) responsible for the possible association between
oligohydramnios and lung hypoplasia?
I. Abnormal carbohydrate metabolism
II. Mechanical restriction of the chest wall
III. Interference with fetal breathing
IV. Failure to produce fetal lung liquid
a. I and III only
b. II and III only
c. I, II, and IV only
d. II, III, and IV only
CORRECT ANS: D
Oligohydramnios, a reduced quantity of amniotic fluid present for an extended period of time,
with or without renal anomalies, is associated with lung hypoplasia. The mechanisms by
which amniotic fluid volume influences lung growth remain unclear. Possible explanations for
reduced quantity of amniotic fluid include mechanical restriction of the chest wall,
interference with fetal breathing, or failure to produce fetal lung liquid. These clinical and
experimental observations possibly point to a common denominator, lung stretch, as being a
major growth stimulant.
REF: pp. 6-7
5. What is the purpose of the substance secreted by the type II pneumocyte?
a. To increase the gas exchange surface area
b. To reduce surface tension
c. To maintain lung elasticity
d. To preserve the volume of the amniotic fluid
RESPIRATORY CARE 5th EDITION BY WALSH/ COMPLETE
CHAPTERS 1-36 PASS QUARANTEED.
, Table of Contents
Chapter 1: Fetal Lung Development ...........................................................................................................................................3
Chapter 2: Fetal Gas Exchange and Circulation Test Bank .........................................................................................................6
Chapter 3: Antenatal Assessment and High Risk Delivery Test Bank........................................................................................9
Chapter 4: Exam and Assessment of the Neonatal and Pediatric Patient Test Bank .................................................................18
Chapter 5: Pulmonary Function Testing and Bedside Pulmonary Mechanics Test Bank ..........................................................31
Chapter 6: Radiographic Assessment Test Bank ......................................................................................................................38
Chapter 7: Bronchoscopy Test Bank ........................................................................................................................................45
Chapter 8: Invasive Blood Gas Analysis and Monitoring Test Bank ......................................................................................53
Chapter 9: Noninvasive Monitoring in Neonatal and Pediatric Care Test Bank .......................................................................63
Chapter 10: Oxygen Administration Test Bank .......................................................................................................................70
Chapter 11: Aerosols and Administration of Medication Test Bank ........................................................................................75
Chapter 12: Airway Clearance Techniques and Lung Volume Expansion Test Bank ...............................................................83
Chapter 13: Airway Management Test Bank ...........................................................................................................................92
Chapter 14: Surfactant Replacement Therapy .......................................................................................................................101
Chapter 15: Non-invasive Mechanical Ventilation and Continuous Positive Pressure of the Neonate...............................103
Chapter 16: Noninvasive Mechanical Ventilation of the Infant and Child Answers to Assessment Questions ......................110
Chapter 16 Noninvasive Mechanical Ventilation of the Infant and Child ..............................................................................111
Chapter 17- Invasive Mechanical Ventilation of the Neonate and Pediatric Patient..............................................................121
Chapter 18: Administration of Gas Mixtures Test Bank........................................................................................................129
Chapter 19, Extracorporeal Membrane Oxygenation.............................................................................................................137
Chapter 20- Pharmacology .....................................................................................................................................................141
Chapter 21: Thoracic Organ Transplantation Test Bank ...............................................................................................................147
Chapter 22: Neonatal Pulmonary Disorders ..........................................................................................................................154
Chapter 22: Neonatal Pulmonary Disorders Answers to Case Studies ...................................................................................157
Chapter 23 Surgical Disorders in Childhood that Affect Respiratory Care ............................................................................159
Chapter 24: Congenital Cardiac Defects Test Bank ................................................................................................................164
Chapter 25 Pediatric Sleep-Disordered Breathing ..................................................................................................................174
Chapter 26: Pediatric Airway Disorders and Parenchymal Lung Diseases .............................................................................184
Chapter 27: Asthma Test Bank .................................................................................................................................................193
Chapter 28: Cystic Fibrosis Test Bank ....................................................................................................................................200
Chapter 29: Acute Respiratory Distress Syndrome Test Bank ................................................................................................206
Chapter 30: Shock...................................................................................................................................................................213
Chapter 31: Pediatric Trauma Test Bank .................................................................................................................................219
Chapter 32: Disorders of the Pleura ........................................................................................................................................238
Chapter 33: Neurological and Neuromuscular Disorders ......................................................................................................242
Chapter 34 Pediatric Emergencies ..........................................................................................................................................248
Chapter 35: Home Care of the Postpartum Family .................................................................................................................263
Chapter 36: Quality and Safety ...............................................................................................................................................269
, Chapter 1: Fetal Lung Development
Walsh: Neonatal & Pediatric Respiratory Care 5th Edition Test Bank (2020)
QNS WITH MUTIPLE CHOICES
1. Which of the following phases of human lung development is characterized by the formation
of a capillary network around airway passages?
a. Pseudoglandular
b. Saccular
c. Alveolar
d. Canalicular
CORRECT ANS: D
The canalicular phase follows the pseudoglandular phase, lasting from approximately 17
weeks to 26 weeks of gestation. This phase is so named because of the appearance of vascular
channels, or capillaries, which begin to grow by forming a capillary network around the air
passages. During the pseudoglandular stage, which begins at day 52 and extends to week 16
of gestation, the airway system subdivides extensively and the conducting airway system
develops, ending with the terminal bronchioles. The saccular stage of development, which
takes place from weeks 29 to 36 of gestation, is characterized by the development of sacs that
later become alveoli. During the saccular phase, a tremendous increase in the potential gas-
exchanging surface area occurs. The distinction between the saccular stage and the alveolar
stage is arbitrary. The alveolar stage stretches from 39 weeks of gestation to term. This stage
is represented by the establishment of alveoli.
REF: pp. 3-5
2. Regarding postnatal lung growth, by approximately what age do most of the alveoli that will
be present in the lungs for life develop?
a. 6 months
b. 1 year
c. 1.5 years
d. 2 years
CORRECT ANS: C
Most of the postnatal formation of alveoli in the infant occurs over the first 1.5 years of life.
At 2 years of age, the number of alveoli varies substantially among individuals. After 2 years
of age, males have more alveoli than do females. After alveolar multiplication ends, the
alveoli continue to increase in size until thoracic growth is completed.
REF: p. 6
3. The respiratory therapist is evaluating a newborn with mild respiratory distress due to tracheal
stenosis. During which period of lung development did this problem develop?
, a. Embryonal
b. Saccular
c. Canalicular
d. Alveolar
CORRECT ANS: A
The initial structures of the pulmonary tree develop during the embryonal stage. Errors in
development during this time may result in laryngeal, tracheal, or esophageal atresia or
stenosis. Pulmonary hypoplasia, an incomplete development of the lungs characterized by an
abnormally low number and/or size of bronchopulmonary segments and/or alveoli, can
develop during the pseudoglandular phase. If the fetus is born during the canalicular phase
(i.e., prematurely), severe respiratory distress can be expected because the inadequately
developed airways, along with insufficient and immature surfactant production by alveolar
type II cells, gives rise to the constellation of problems known as infant respiratory distress
syndrome.
REF: p. 6
4. Which of the following mechanisms is (are) responsible for the possible association between
oligohydramnios and lung hypoplasia?
I. Abnormal carbohydrate metabolism
II. Mechanical restriction of the chest wall
III. Interference with fetal breathing
IV. Failure to produce fetal lung liquid
a. I and III only
b. II and III only
c. I, II, and IV only
d. II, III, and IV only
CORRECT ANS: D
Oligohydramnios, a reduced quantity of amniotic fluid present for an extended period of time,
with or without renal anomalies, is associated with lung hypoplasia. The mechanisms by
which amniotic fluid volume influences lung growth remain unclear. Possible explanations for
reduced quantity of amniotic fluid include mechanical restriction of the chest wall,
interference with fetal breathing, or failure to produce fetal lung liquid. These clinical and
experimental observations possibly point to a common denominator, lung stretch, as being a
major growth stimulant.
REF: pp. 6-7
5. What is the purpose of the substance secreted by the type II pneumocyte?
a. To increase the gas exchange surface area
b. To reduce surface tension
c. To maintain lung elasticity
d. To preserve the volume of the amniotic fluid
